跳至主要内容
临床试验/NCT05352737
NCT05352737已完成不适用

A Retrospective Study Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer---focusing on Metastasis, Chemotherapy Resistance, and Ageing Effects

KU Leuven1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
KU Leuven
入组人数
300
试验地点
1
主要终点
MMA levels

研究概览

简要总结

This project aims to investigate the role of MMA in breast cancer. To this end, we will measure MMA on serum samples collected at the time of breast cancer diagnosis, to investigate the role of MMA in predicting long-term recurrence risk, response to neoadjuvant chemotherapy, and its association with age and clinical frailty.

详细描述

This project aims to investigate the role of MMA in breast cancer. To this end, we will measure MMA on serum samples collected at the time of breast cancer diagnosis, to investigate the role of MMA in predicting long-term recurrence risk, response to neoadjuvant chemotherapy, and its association with age and clinical frailty. If the role of baseline serum MMA in therapy resistance and/or metastasis is confirmed, our study could be further extended by evaluating SOX4 expression in the tumor tissues (SOX4 is activated by MMA, and SOX4 induces EMT (epithelial to mesenchymal transition) and the metastasis process.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients older than 18 years at diagnosis.
  • First diagnosis of invasive breast cancer.
  • All pathological parameters are available to identify histological subtype according to standard procedures.
  • Availability of frozen serum samples at diagnosis.
  • Voluntarily signed Informed Consent obtained before blood drawing for biobanking was performed.

排除标准

  • Pregnant at diagnosis.
  • stage 0 disease (in situ).
  • Bilateral BC at diagnosis or multifocal unilateral BC with different histology.
  • Other subtypes than Invasive ductal carcinoma.
  • Prior breast cancer.

结局指标

主要结局

MMA levels

时间窗: baseline

baseline serum MMA levels in pre-defined patients

次要结局

未报告次要终点

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qi Wu

Dr.

KU Leuven

研究点 (1)

Loading locations...

相似试验